Cargando…
Utilization of kinase inhibitors as novel therapeutic drug targets: A review
Kinase inhibitors are a significant and continuously developing division of target therapeutics. The drug discovery and improvement efforts have examined numerous attempts to target the signaling pathway of kinases. The Kinase inhibitors have been heralded as a game-changer in cancer treatment. For...
Autores principales: | NISHAL, SUCHITRA, JHAWAT, VIKAS, GUPTA, SUMEET, PHAUGAT, PARMITA |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tech Science Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10208038/ https://www.ncbi.nlm.nih.gov/pubmed/37305347 http://dx.doi.org/10.32604/or.2022.027549 |
Ejemplares similares
-
Innovation in cancer therapeutics and regulatory perspectives
por: Sharma, Pinky, et al.
Publicado: (2022) -
Angiotensin Converting Enzyme Gene Insertion/Deletion Polymorphism Is Not Responsible for Antihypertensive Therapy Induced New Onset of Type 2 Diabetes in Essential Hypertension
por: Jhawat, Vikas, et al.
Publicado: (2019) -
Alpha Adducin (ADD1) Gene Polymorphism and New Onset of Diabetes Under the Influence of Selective Antihypertensive Therapy in Essential Hypertension
por: Gupta, Sumeet, et al.
Publicado: (2019) -
Therapeutic Drug Monitoring of Kinase Inhibitors in Oncology
por: van der Kleij, Maud B. A., et al.
Publicado: (2023) -
Novel targets for potential therapeutic use in Diabetes mellitus
por: Dhankhar, Sanchit, et al.
Publicado: (2023)